For the successful development of a vaccine to be used against a pathogen, it is necessary that
A) the surface antigens of the pathogen not change. B) a rearrangement of the B cell receptor antibodies takes place. C) all of the surface antigens on the pathogen be identified. D) the pathogen has only one epitope. E) the MHC molecules are heterozygous.